Wagenvoort, Gertjan H J <br/><br/>
Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands.  [electronic resource] 

 -  Vaccine  Jan 2016 
 - 334-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2015.11.048  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Bacteremia--epidemiology<br/>Female<br/>Heptavalent Pneumococcal Conjugate Vaccine--administration & dosage<br/>Humans<br/>Male<br/>Meningitis, Bacterial--epidemiology<br/>Middle Aged<br/>Netherlands--epidemiology<br/>Pneumococcal Infections--epidemiology<br/>Risk Assessment<br/>Serogroup<br/>Streptococcus pneumoniae--classification<br/>Survival Analysis<br/>Young Adult